Clinical Trial Update: Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial of carboxyamidotriazole for stage III/IV non-small cell lung cancer has completed, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Carboxyamidotriazole (carboxyamidotriazole)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2010-12-22